Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation

NCT00948727 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Stem Cell Transplantation
Graft Versus Host Disease

Interventions

BEHAVIORAL: Dose adaptation according to CN activity monitoring
DRUG: Cyclosporine (CsA)

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]